Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

of the non-Hodgkin lymphomas (NHL) in the United States. These types of lymphomas start in early forms of B lymphocytes (B cells). The most common types of B-cell lymphomas are listed below. Diffuse ...

Lymphomas are cancers that start in white blood cells called lymphocytes. There are 2 main types of lymphoma: Hodgkin lymphoma (HL) Non-Hodgkin lymphoma (NHL ... These cells are usually an abnormal ...

Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces the completion of ...

Explore Allogene's innovative CAR-T therapies targeting cancer & autoimmune diseases. ASCO updates on ALLO-316 could validate ...

The Nordic Protocol is a type of chemoimmunotherapy treatment. It combines chemotherapy (which slows the growth of cancer ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that it will present latest clinical ...

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

The researchers also observed significant increases in mortality for at least 1 age group for the following cancers: testicular cancer, uterine cancer, female breast cancer, bone and joint cancer, ...

LADENBURG, Germany I May 27, 2025 I Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), ...